CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GeoVax Labs, Inc.

GOVX
$1MMicro Cap

Next catalyst

Phase 2December 2026

Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1

COVID-19 Infection

Get an email about GOVX's next catalysts

Track GeoVax Labs (GOVX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (earnings).See the timeline

Catalyst Timeline

2 upcoming, 0 past

Earnings

GOVX Earnings Report

November 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-1.02 | FQ end Sep/2026 | Call: tbd

Phase 2Next

Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 Phase 2 Est. Readout

December 2026~Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S163

Estimated primary completion for Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 trial (NCT04977024) in COVID-19 Infection. Topline data typically follows completion by weeks to months.

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaSMYRNA

Frequently asked questions

What is in GeoVax Labs, Inc.'s drug pipeline?β†’

CatalystAlert tracks 5 drug candidates in GeoVax Labs, Inc.'s (GOVX) pipeline across Phase 2. Its lead program is Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is GeoVax Labs, Inc.'s next FDA catalyst?β†’

GeoVax Labs, Inc.'s (GOVX) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track GOVX biotech catalysts?β†’

Add GOVX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GeoVax Labs, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply